Launch of FyoniBio’s CHOFlow® technology
Enhanced Potency meets Outstanding Manufacturability
We are pleased to announce that we have successfully launched our new CHOFlow® technology for the production of afucosylated ADCC enhanced antibodies. CHOFlow® unifies excellent productivity rates and exceptionally stable and robust production processes of our CHOnamite® host cell line with a proven genetic glyco-optimization strategy.